Found 18 matching trials
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer PHASE2 This trial is to further study the safety and effectiveness of autologous g...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. EARLY_PHASE1 Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Show More Location
Biogenea Pharmaceuticals Ltd
Learn More & Join Trial
Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma PHASE1 The purpose of this research study is to see if the combination of HSPPC-96...
Show More Location
UTHealth Memorial Hermann Cancer Center
Learn More & Join Trial
A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma PHASE2 Primary Objectives:
* To document the efficacy of treatment with autologou...
Show More Location
M.D. Anderson Cancer Center
Learn More & Join Trial
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer PHASE3 Determine whether patients receiving adjuvant HSPPC-96 treatment after surg...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma PHASE3 The primary goal of this study is to determine if people with metastatic me...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) PHASE2 Background:
Glioblastoma (GBM) refers to a specific kind of brain cancer c...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer PHASE3 This is an international, open label, randomized phase 3 trial in which pat...
Show More Location
Multiple Locations
Learn More & Join Trial
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma PHASE1 Vaccines made from a person's tumor cells, such as gp96 heat shock protein-...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma PHASE2 The goal of this trial is to determine the safety of HSPPC-96 and which rou...
Show More Location
Multiple Locations
Learn More & Join Trial